Literature DB >> 12763929

Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control.

Xiaxin Li1, P Artur Plett, Yanzhu Yang, Ping Hong, Brian Freie, Edward F Srour, Christie M Orschell, D Wade Clapp, Laura S Haneline.   

Abstract

The pathogenesis of bone marrow failure in Fanconi anemia is poorly understood. Suggested mechanisms include enhanced apoptosis secondary to DNA damage and altered inhibitory cytokine signaling. Recent data determined that disrupted cell cycle control of hematopoietic stem and/or progenitor cells disrupts normal hematopoiesis with increased hematopoietic stem cell cycling resulting in diminished function and increased sensitivity to cell cycle-specific apoptotic stimuli. Here, we used Fanconi anemia complementation type C-deficient (Fancc-/-) mice to demonstrate that Fancc-/- phenotypically defined cell populations enriched for hematopoietic stem and progenitor cells exhibit increased cycling. In addition, we established that the defect in cell cycle regulation is not a compensatory mechanism from enhanced apoptosis occurring in vivo. Collectively, these data provide a previously unrecognized phenotype in Fancc-/- hematopoietic stem/progenitor cells, which may contribute to the progressive bone marrow failure in Fanconi anemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763929     DOI: 10.1182/blood-2003-02-0536

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1.

Authors:  Kalindi Parmar; Jungmin Kim; Stephen M Sykes; Akiko Shimamura; Patricia Stuckert; Kaya Zhu; Abigail Hamilton; Mary Kathryn Deloach; Jeffery L Kutok; Koichi Akashi; D Gary Gilliland; Alan D'andrea
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

2.  The GOD of hematopoietic stem cells: a clonal diversity model of the stem cell compartment.

Authors:  C E Muller-Sieburg; H B Sieburg
Journal:  Cell Cycle       Date:  2006-02-15       Impact factor: 4.534

Review 3.  Mouse models of Fanconi anemia.

Authors:  Kalindi Parmar; Alan D'Andrea; Laura J Niedernhofer
Journal:  Mutat Res       Date:  2009-04-10       Impact factor: 2.433

4.  Genetic correction of hematopoiesis in Fanconi anemia: the case for a non-HSC-autonomous defect.

Authors:  Amy M Skinner; Peter Kurre
Journal:  Mol Ther       Date:  2009-08       Impact factor: 11.454

Review 5.  Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis.

Authors:  Cristina Mirantes; Emmanuelle Passegué; Eric M Pietras
Journal:  Exp Cell Res       Date:  2014-08-19       Impact factor: 3.905

6.  FANCC suppresses short telomere-initiated telomere sister chromatid exchange.

Authors:  David B Rhee; Yisong Wang; Melissa Mizesko; Fang Zhou; Laura Haneline; Yie Liu
Journal:  Hum Mol Genet       Date:  2009-12-18       Impact factor: 6.150

7.  The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression.

Authors:  Caroline C Huard; Cédric S Tremblay; Audrey Magron; Georges Lévesque; Madeleine Carreau
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

8.  Exonuclease 1 is a critical mediator of survival during DNA double strand break repair in nonquiescent hematopoietic stem and progenitor cells.

Authors:  Amar Desai; Yulan Qing; Stanton L Gerson
Journal:  Stem Cells       Date:  2014-02       Impact factor: 6.277

9.  Mesenchymal stem/progenitor cells promote the reconstitution of exogenous hematopoietic stem cells in Fancg-/- mice in vivo.

Authors:  Yan Li; Shi Chen; Jin Yuan; Yanzhu Yang; Jingling Li; Jin Ma; Xiaohua Wu; Marcel Freund; Karen Pollok; Helmut Hanenberg; W Scott Goebel; Feng-Chun Yang
Journal:  Blood       Date:  2009-01-07       Impact factor: 22.113

10.  HES1 is a novel interactor of the Fanconi anemia core complex.

Authors:  Cédric S Tremblay; Feng F Huang; Ouassila Habi; Caroline C Huard; Chantal Godin; Georges Lévesque; Madeleine Carreau
Journal:  Blood       Date:  2008-06-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.